Tumor-suppressor protein p53, the 'guardian of the genome', is critical in maintaining cellular homeostasis and genomic stability. Earlier, we have reported the discovery of internal ribosome entry sites (IRESs) within the p53 mRNA that regulate the translation of the full length and its N-terminal-truncated isoform, DN-p53. Polypyrimidine tract-binding protein (PTB) is an IRES trans-acting factor that positively regulates the IRES activities of both p53 isoforms by relocating from nucleus to the cytoplasm during stress conditions. Here we have demonstrated the putative contact points of PTB on the p53 IRES RNA. Studies on mutations that occur naturally in the 5 0 untranslated region (5 0 UTR) in p53 mRNA were lacking. We have investigated a naturally occurring C-to-T single-nucleotide polymorphism (SNP) first reported in human melanoma tumors. This SNP is at position 119 in the 5 0 UTR of p53 mRNA and we demonstrate that it has consequences on the translational control of p53. Introduction of this SNP has led to decrease in cap-independent translation from p53 5 0 UTR in bicistronic reporter assay. Further, the effects of this SNP on cap-independent translation have been studied in the context of p53 cDNA as well. Interestingly, the 5 0 UTR with this SNP has shown reduced binding to PTB that can be corroborated to its weaker IRES activity. Previously, it has been shown that G2-M checkpoint, DNA-damaging stress and oncogenic insult favor IRES-mediated translation. Under similar conditions, we demonstrate that this SNP interferes with the enhancement of the IRES activity of the 5 0 UTR. Taken together, the results demonstrate for the first time that SNP in the 5 0 UTR of the p53 mRNA might have a role in translational control of this critical tumor-suppressor gene.
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Tumor-suppressor protein p53, the 'guardian of the genome', is critical in maintaining cellular homeostasis and genomic stability. Earlier, we have reported the discovery of internal ribosome entry sites (IRESs) within the p53 mRNA that regulate the translation of the full length and its N-terminal-truncated isoform, DN-p53. Polypyrimidine tract-binding protein (PTB) is an IRES trans-acting factor that positively regulates the IRES activities of both p53 isoforms by relocating from nucleus to the cytoplasm during stress conditions. Here we have demonstrated the putative contact points of PTB on the p53 IRES RNA. Studies on mutations that occur naturally in the 5 0 untranslated region (5 0 UTR) in p53 mRNA were lacking. We have investigated a naturally occurring C-to-T single-nucleotide polymorphism (SNP) first reported in human melanoma tumors. This SNP is at position 119 in the 5 0 UTR of p53 mRNA and we demonstrate that it has consequences on the translational control of p53. Introduction of this SNP has led to decrease in cap-independent translation from p53 5 0 UTR in bicistronic reporter assay. Further, the effects of this SNP on cap-independent translation have been studied in the context of p53 cDNA as well. Interestingly, the 5 0 UTR with this SNP has shown reduced binding to PTB that can be corroborated to its weaker IRES activity. Previously, it has been shown that G2-M checkpoint, DNA-damaging stress and oncogenic insult favor IRES-mediated translation. Under similar conditions, we demonstrate that this SNP interferes with the enhancement of the IRES activity of the 5 0 UTR. Taken together, the results demonstrate for the first time that SNP in the 5 0 UTR of the p53 mRNA might have a role in translational control of this critical tumor-suppressor gene.
INTRODUCTION
Human TP53 gene encodes the tumor-suppressor p53 protein that has a major role in maintaining genomic integrity and cellular homeostasis and inhibiting cell transformation. It is triggered by cellular stresses, such as DNA damage, oncogene activation, mitotic impairment and oxidative stress, that in turn lead to DNA repair, cell-cycle arrest, senescence or apoptosis. 1, 2 It is one of the most commonly mutated genes in majority of cancers. 3 The p53 pathway is often activated during conditions such as ER stress or apoptosis that lead to global attenuation of capdependent translation. An alternative mode of cap-independent translation initiation mediated by internal entry of ribosomes on p53 mRNA maintains the expression of p53 and its N-terminaltruncated isoform DN-p53 (alternatively, p53/47 or D40p53). Thus, p53 mRNA has additional layers of regulation that decide the production of relative amounts of isoforms. Two internal ribosome entry site (IRES) elements residing within p53 mRNA mediate its translation under conditions where cap-dependent translation is reduced. The first IRES, located in the 5 0 untranslated region (UTR), was shown to regulate p53 translation in response to etoposideinduced DNA damage, where cap-dependent translation is inhibited by increased association of translation initiation factor eIF4E with its binding protein 4E-BP1. 4 A number of proteins, such as ribosomal protein L26 and nucleolin, were identified to interact with p53 5 0 UTR and regulate its translation both at basal levels and in response to different stress conditions. 5 A second IRES, located in the coding sequence between the translation initiation codons of p53 and its translational isoform DN-p53, was shown to regulate DN-p53 translation. 6, 7 The IRES responsible for the translation of p53 was observed to be most active at the G2-M transition. As p53 activity is required during this phase of the cell cycle, IRES-mediated translation might be required for maintaining basal levels of p53 protein at the M phase when there is a decrease in canonical cap-dependent translation. On the other hand, the activity of IRES responsible for the translation of DN-p53 predominates at the G1-S transition. 7 DN-p53 translation is upregulated in response to ER stress, under conditions in which cap-dependent translation is inhibited by eIF2a phosphorylation. 6, 8 IRES-mediated translation of p53 has been linked to disease. A recent study has shown that during oncogene-induced senescence, a switch between cap-and IRES-dependent translations occurs. During this switch, the IRES element positioned in the 5 0 UTR of p53 is engaged and facilitates p53 translation. 9 This study concludes that in forms of X-linked dyskeratosis congenita where dyskerin is mutated, IRES-dependent translation is compromised in the face of oncogenic insult. Another independent study has come up with similar results. 10 Several studies have demonstrated the requirement of cellular RNA-binding proteins, termed as IRES trans-acting factors (ITAFs), as critical for the function of cellular and viral IRESs, that might act as RNA chaperones either to attain or maintain the correct three-dimensional IRES structure required for the efficient assembly of initiation complex and/or the recruitment of ribosomes.
Many ITAFs have been shown to relocate from the nucleus to the cytoplasm, and it is possible that such subcellular redistribution is critical for their role as ITAFs under stress conditions. 12 We had demonstrated that polypyrimidine tract-binding protein (PTB) turns on p53 IRES function and regulates the differential expression of the p53 isoforms. 13 In that study, treatment with DNA-damaging agent, doxorubicin, causes increased translocation of PTB protein from nucleus to cytoplasm. It appears that the relative abundance of PTB in the cytoplasm differentially regulates IRES-mediated translation of the p53 isoforms under normal and stress conditions. 14 A major lesson from the human tumor-associated p53 mutation databases is that TP53 is unusually vulnerable to a large range of single-nucleotide alterations that compromise the function of the wild type (WT) protein and can even confer new oncogenic activities. Features that suggest a potential phenotypical consequence include polymorphisms in the coding sequence that alter amino-acid sequence (most of the p53 mutations lie in its DNAbinding domain), or variants that affect expression levels, for example, polymorphisms in promoters, splice sites, UTRs or protein-binding element. 15 One such mutation is the L22L (CTA to CTG) single silent mutation in the coding region of RNA, upstream to the second initiator codon (for DN-p53). It generates p53 mRNA that translates p53 at a constant rate in the presence or absence of Mdm2. 6 We further characterized this mutant and showed that it compromises the IRES activity necessary for the synthesis of DN-p53.
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In the current study, we have identified the PTB contact points on p53 IRES RNA. Additionally, we have characterized single-nucleotide polymorphisms (SNPs), namely A24G (SNP1) and C119T (SNP2), in the p53 5 0 UTR. One of these SNPs, C119T, has been reported in human melanoma samples 17 and has been mapped to the 5 0 UTR in p53 knowledge base. 18 Curiously, WT C nucleotide in the 119th position in p53 5 0 UTR has been found to be evolutionarily conserved. Inclusion of SNP2-5 0 UTR in a bicistronic reporter has led to a decrease in the 5 0 UTR IRES activity. In vitro PTB binding and ex vivo PTB-knockdown studies have shown that SNP2-5 0 UTR is deficient in PTB binding and hence is refractory to PTB knockdown. There are differences in cellular protein-binding profile of SNP2-5 0 UTR compared with the WT. Doxorubicin-induced stress and oncogenic insult have not been able to induce the expression of IRES activity from the SNP2-5 0 UTR to similar levels of the WT. We provide the first evidence that SNPs in 5 0 UTR of p53 affect its translational activity in physiological and oncogenic stresses that may have a direct bearing in cancer development and progression.
RESULTS PTB binds to multiple sites within p53 IRES RNA PTB was reported to bind to p53 IRES RNA in our earlier work. 13 To investigate the regions in p53 IRES RNA that broadly interact with PTB, RNA foot-printing assay was performed. The results (Figure 1a) show that PTB can indeed protect the specific regions in p53 IRES RNA from RNase T1 digestion. RNase T1-induced cleavage of p53 IRES RNA was progressively inhibited by increasing concentrations of PTB at G residues at positions 113, 132, 140, 160, 162, 165, 167 and 195 ( Figure 1a , filled circles).
To investigate the putative contact points of PTB on the p53 IRES RNA (1-251nucleotides), a toe-printing assay of PTB on p53 RNA was performed. As the p53 5 0 UTR folds into a fairly stable secondary structure, some specific pauses were observed even in the absence of protein (Figure 1b, lane 1) . Distinct toe prints were discerned at C80, C96, C111, A135 (interestingly, the first nucleotide of p53 message), C151, U158, U163, C187, C193, C197, C207, C210 and C 214.
The results of the foot-printing and toe-printing assays are schematically represented in Figure 1c . The footprints and toeprints are shown as empty and filled circles, respectively. The stem rich in pyrimidines spanning nucleotides 189-194 (as marked in the rectangular box in Figure 1c ) could be a potential site for PTB binding as suggested by unpublished data from our laboratory. Similarly, the secondary structure in the neighborhood of the first ATG, the stem-loop spanning nucleotides 95-119 and the single-stranded bulge from nucleotides 150-167 probably are PTB-binding regions in the IRES.
Dual-luciferase assays were performed with a bicistronic vector 7, 13 where the 5 0 UTR of p53 mRNA was present in the intercistronic region of Renilla luciferase and firefly luciferase cDNAs (Supplementary Figure 1a) . Results suggest that deletion of nucleotides 120-134 from the 5 0 UTR diminishes the IRES activity by about 38%, and deleting 15 nucleotides further into the IRES (105-119 nuleotides) decreases it by about 54% (Supplementary Figure 1b) . Progressive 15 nucleotide deletions do not change the IRES activity further. Although we cannot rule out structural alterations in the deleted 5 0 UTR constructs, however, it might be possible that these deletions are deficient in PTB binding and may lead to decreased IRES activity.
Cytosine at position 119 in p53 5 0 UTR is conserved across different species p53 cDNAs from 12 different species of mammals, avians, amphibians and fish (corresponding mRNA sequences mentioned in Supplementary Table 2 ) were aligned using MultAlin program (http://multalin. toulouse.inra.fr/multalin/), such that their initiator ATGs were at the same position. C119 was found to be present in 15 nucleotides upstream of initiator ATG in all of these species (Supplementary  Table 2 ). Interestingly, this particular nucleotide was first reported to have a C-to-T polymorphism in the TP53 gene in human melanoma tumors, 17 and this SNP is mapped to p53 5 0 UTR of reference p53 nucleotide sequence (GenBank accession number X54156) in p53 knowledge base (http://p53.bii.a-star.edu.sg). 18 The evolutionary distances of the p53 cDNAs (as in table, Supplementary Table 2) were represented as an unrooted dendrogram as generated from ClustalW program (Supplementary Figure 3) that reflects the similarities in the p53 cDNA sequences used for the alignment.
C-to-T change in position 119 in p53 5 0 UTR alters the IRES activity under physiological conditions Another SNP (SNP1, an A to G polymorphism in the 24th nucleotide at p53 5 0 UTR) was selected from IARC-TP53 database (http://www,p53.iarc.fr/) (mutation ID 3506) for comparison ( Figure 2a ). The C119T (SNP2) and A24G (SNP1) changes were incorporated separately in the p53 5 0 UTR in the intercistronic region of a dual-luciferase bicistronic construct described elsewhere. 7, 13 Expression of firefly luciferase is mediated by the polymorphic p53 5 0 UTR from this construct. Interestingly, SNP2-5 0 UTR displayed a weaker IRES activity compared with the WT 5 0 UTR, whereas SNP1-5 0 UTR had the opposite effect (Figure 2b ). The SNP2 lies in a position that seems to be important for binding to PTB as discussed above. Hence, we wanted to study the effect of knocking down PTB on the IRES activity from mutant 5 0 UTRs. After 48 h of silencing PTB by transient transfection of small interfering RNA (siRNA), the expression of firefly luciferase from WT and SNP1-5 0 UTRs decreased, whereas that from SNP2-5 0 UTR was low initially and it did not decrease further (Figure 2b ). The lysates were tested for equal knockdown of PTB (Figure 2c ). These results were validated further by knocking down PTB with increasing concentrations of siRNA, where 15 nM of si-PTB effectively decreased expression of p53 from WT and SNP1-p53 5 0 UTR but not from SNP2-5 0 UTR (Figure 2d ). Probing DN-p53 levels show that the ratio of full-length p53/DN-p53 are different for SNP2-5 0 UTR, with higher DN-p53, compared with WT-or SNP1-5 0 UTR (Supplementary Figure 4) . Collectively, these results suggest that SNP2-5 0 UTR is not responsive to PTB silencing under Effect of SNP at the 5 0 UTR on p53 translation D Khan et al the experimental conditions used and subsequent decrease in IRES-mediated expression of p53. Correlating this with the inherent weaker activity of SNP2-5 0 UTR, it may be envisaged that there are changes in its PTB-binding ability.
The cytoplasmic level of PTB changes with cell-cycle stages, with the maximum cytoplasmic content at G2-M checkpoint. 19 Earlier studies have shown that nuclear cytoplasmic relocalization of PTB is important also under DNA-damage stress and is critical for IRES-driven expression of p53 under such condition. 13 So we wanted to address the effect of G2-M checkpoint on IRES-mediated p53 expression in cells in which PTB had been knocked down. The SNP2-5 0 UTR displayed lower levels of firefly luciferase expres- 0 UTR compared with SNP2-5 0 UTR. Interestingly, this increase was absent in cells with knocked down PTB for WT 5 0 UTR, whereas the expression was unaffected from SNP2-5 0 UTR (Figure 3b ). We also confirmed that silencing of PTB, in the background of p53 expression in the H1299 cells, does not change the population of mitotic cells considerably (Figure 3c ).
Blocking the cells expressing p53 from WT-or SNP2-5 0 UTRcDNA at G1-S checkpoint by double-thymidine treatment and their subsequent release revealed altered cell-cycle dynamics in the case of p53 produced from SNP2-5 0 UTR (Supplementary Figure 5) . Briefly, for G1/S block, the cells were treated twice with 5 mM thymidine, with an intermediate release of 6 h. After the second block, the cells were released from the block and then harvested at 0, 1.5, 3.5, 7.5, 8.5, 9.5 and 11.5 h. Fluorescenceactivated cell sorting (FACS) analysis revealed that although all cells could not be mobilized through the cell cycle and many remained at G1 phase for both WT-and SNP2-5 0 UTR, more cells showed earlier release from the G1-S block (by 1.5 h) and exhibited faster progression to mitosis (by 8.5 h) for SNP2-5 0 UTRp53 (Supplementary Figure 5 ). p53 mRNA with C119T 5 0 UTR shows differential association with polysomes To test more directly whether the effects of SNP2 result from selective inhibition of translation initiation from the p53 IRES, the effect of this SNP on the polysomal distribution of the mRNA was assessed. One representative polysomal profile is shown in Figure 4a . The distribution of p53 mRNA in the non-polysomal, light polysomal (disomes and trisomes) and heavy polysomal pooled fractions was examined by semiquantitative reversetranscriptase PCR and the levels were normalized to 18S rRNA ( Figure 4b ). The C119T change in the 5 0 UTR induced a shift of p53 mRNA to non-polysomal part compared with WT IRES. In contrast, the distribution pattern of p53 mRNA with SNP1-5 0 UTR was nearly similar in all the pools (Figure 4b ). Thus, both these SNPs change the association of p53 mRNA with the polysomes, and specifically in the case of SNP2, there is depletion in the polysomal fraction indicating reduced translation efficiency.
To investigate de novo protein synthesis, we also performed metabolic labeling with 35 S-methionine in H1299 cells after overexpressing p53 from WT-, SNP1-or SNP2-IRES, followed by immunoprecipitation with DO-1 monoclonal antibody that recognizes an epitope spanning 11-25 amino acids in the N-terminus of p53 (Supplementary Figure 6) . SNP2-IRES (lane 4) was found to be deficient in producing p53 up to the levels of either the WT-(lane 2) or SNP1-IRES (lane 3).
C-to-T change in 5
0 UTR affects ribosomal assembly on p53 IRES RNA It was interesting to investigate if functional ribosome complex formation near the initiator AUG of p53 IRES RNA would be affected in C119T 5 0 UTR. For this, sucrose-gradient centrifugation experiments with uncapped, ribosome-bound [ 32 P]-labeled p53 IRES RNA were performed followed by the analysis of 48 and 80S ribosomal peaks. When WT RNA was used, two peaks were observed, corresponding to 80 and 48S ribosomes associated with the labeled p53 RNA (Figure 4c , top panel). When the experiments were performed with C119T 5 0 UTR RNA, we observed an increase in 80S peak (Figure 4c , top panel). For WT RNA, addition of cycloheximide resulted in the increase in 80S peak due to the trapping of 80S ribosomal complexes on the RNA (Figure 4c , middle panel), whereas similar treatment did not increase the 80S peak for C119T 5 0 UTR further ( Figure 4c , bottom panel). It might be possible that for C119T 5 0 UTR RNA, the 80S initiation complex was poorly cleared from initiator AUG or 60S subunits and nonfunctional 80S complexes were trapped there, resulting in a translational block, similar to what was observed for the WT RNA in presence of cycloheximide. These results corroborate the earlier observations that SNP2-C119T 5 0 UTR is found preferentially associated with the cellular non-polysomal fraction that includes monosome-associated RNA and also the fact that SNP2-IRES is less proficient in producing p53 as revealed by in cellulo metabolic labeling.
C119T 5
0 UTR binds differentially to cellular proteins
The ultraviolet (UV) cross-linking of WT, SNP1-and SNP2-5 0 UTRs with translation-competent A549 cell S10 extracts revealed differences in their protein-binding abilities ( Figure 5a ). Compared with its WT counterpart, for SNP2-5 0 UTR (lane 3, Figure 5a ), polypeptides with approximate molecular masses 90, 57, 42, 41 and 40 showed reduced binding and p47 was below level of detection, whereas four other proteins were seen to bind more strongly (p77, p74, p65, p54). (a) Foot-printing assay of PTB protein on p53 IRES RNA using RNase T1. p53 RNA was incubated without (lanes 1 and 2) or with increasing amounts of purified recombinant PTB protein (lanes 3 and 4). The RNA was unmodified (lane 1) or digested with 0.5 U of RNaseT1 (lanes 2, 3, 4 and 5). The unmodified and digested RNAs were reverse transcribed and the resulting cDNAs were resolved in 8% acrylamide-7 M urea PAGE in parallel with a sequencing reaction performed by using the same end-labeled primer. 3) . The RNAs in the ribonucleoprotein complexes were reverse transcribed and the resulting cDNAs were resolved in 8% acrylamide-7 M urea PAGE in parallel with a sequencing reaction performed by using the same primer. The cDNA products terminated at the sites due to protein binding is indicated on the right. (c) Schematic representation of the contact points of PTB protein on putative predicted secondary structure of p53 IRES RNA. The region wherein major PTB contact points are observed in p53 IRES RNA is enlarged. The mapped PTB contact points as observed by foot-printing assay and toe-printing assay are indicated on the predicted secondary structure of p53 ( þ 39) RNA generated by MFOLD.
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IRES activity of C119T 5
0 UTR is weakened under various stress conditions Doxorubicin is a DNA-damaging agent that induces IRESdependent expression of p53 and its isoform DN-p53. 13, 20 The expression of firefly luciferase from SNP2-5 0 UTR was not induced to the same extent compared with the WT (Figure 6a) . Also, the doxorubicin-induced overexpression of p53 was compromised from a bicistronic construct, including SNP2-5 0 UTR-p53 cDNA (Figure 6b ).
Using an oncogenic insult, it was shown that p53 IRES is activated and is critical for oncogene-induced senescence. 9 We overexpressed H-Ras V12 , an activated form of Ras oncogene in H1299 cells. This increased both cap-dependent and capindependent translation in the cell after 48 h, but although the increase of cap-dependent translation from WT and SNP2-5 (Figure 7a ). Similar results were seen for p53 levels from p53 cDNAs (Figure 7b ). The increase in general cap-dependent translation by H-Ras V12 was confirmed using a beta-galactosidase overexpression construct also (Supplementary Figure 7a) . This increase was solely due to H-Ras V12 , and the cells do not have a background beta-galacosidase activity on H-Ras V12 overexpression as otherwise seen in primary cells undergoing oncogene-induced senescence (Supplementary Figure 7b) . p53 can induce apoptosis on DNA damage, one of the pathways involved being cleavage of caspase-3 (35 kDa) to activated 17 and 12 kDa fragments. 21 We checked for the cleavage of caspase-3 by p53 produced from WT-or SNP2-IRES on doxorubicin-induced DNA damage (Supplementary Figure 8) . SNP2-IRES-mediated p53 production was found to be slightly lesser and was deficient in triggering cleavage of caspase-3 on doxorubicin treatment.
Outcome of SNP2 in p53 5 0 UTR: lesser transactivation
As the levels of p53 protein produced from SNP2-IRES were less compared with WT, we next checked the biological outcome in terms of degree of p53-induced transactivation. p21 (WAF1/CIP1) is a transcriptional target of p53. Overexpression of p53 was found to increase the luciferase activity driven by p21 promoter, but this increase was substantially lesser for SNP2-5 0 UTR (Figure 8a ) and this can be correlated with the lower activity of this 5 0 UTR in guiding IRES-mediated expression of p53. With nocodazole treatment, the p21-promoter-driven luciferase expression further increased significantly from WT and SNP-1 5 0 UTR; in contrast, no further increase was seen in the case of SNP2-5 0 UTR (Figure 8a ). One representative western blot for p53 level is shown in Figure 8b .
We also checked the mRNA levels of some known transcriptional targets of p53. Cells were transfected with plasmids expressing WT 5 0 UTR mRNA or C119T 5 0 UTR mRNA (Figure 8c ). RNA was isolated 48 h after transfection and cDNA was synthesized from total RNA followed by real-time PCR for p21, BAX, PIDD, GADD45, SFN and MDM2, whereas actin was used as the reference gene. The mRNA levels of all the genes, except SFN (stratifin that encodes for 14-3-3 sigma protein), decreased for p53 produced from C119T 5 0 UTR mRNA relative to that from WT 5 0 UTR mRNA.
DISCUSSION
PTB had been shown to bind to both the modules of the p53 IRES.
As an ITAF, it positively influences IRES-mediated translation of p53 and its 'little brother' DN-p53; however, binding was found to be higher in the coding region of the IRES compared with the noncoding region, that is, the 5 0 UTR. 13 In the current study, we have mapped the putative regions on p53 IRES RNA that actually bind to PTB. The binding sites are distributed over both the 5 0 UTR (1-134 nucleotides) and the coding region (135-251 nucleotides) of the IRES RNA, with one particular stem in the latter showing several toe and foot prints for PTB. Another such region is a singlestranded region between the initiator AUG of p53 and the particular stem in question. Interestingly, the stem-bulge secondary structure at the initiator AUG of p53 and another stem-loop in the 5 0 UTR also seem to be putative contact regions for PTB. This points to the fact that under certain conditions, PTB mediates the translation of full-length p53 by binding to the low-affinity 5 0 UTR also. Naturally occurring mutations in p53 have held the interest of researchers for a long time for the fact that these can be used as prognostic markers for cancers. A plethora of SNPs, deletions, insertions and consequent amino-acid changes in p53 have been reported. A pro72-to-arg polymorphism in p53 reported years ago 22 is a classic example of a single amino-acid change that has been associated with a multitude of cancers. Another interesting example is that of P47S variant of p53. WT p53 has a proline at codon 47 (P47) that acts as a recognition site for phosphorylation of ser46 by p38 MAPK, which enhances induction of apoptosis. However, o5% of African Americans have a serine at codon 47 (S47) due to a C-to-T SNP. It was shown that the S47 variant of p53 was a poorer substrate for phosphorylation by p38 MAPK, resulting in up to five-fold reduced ability to induce apoptosis compared with WT p53. 23 These mutations, singly or along with concomitant mutants, in the p53 pathway or p53-interacting proteins have been associated to head and neck, breast, blood, cervical, skin, lung and various other cancers in population-wide studies. Majority of these 0 UTR of p53 mRNA and consequent implications in translational control and/or stability of the mRNA. One particular silent mutation, L22L (CTA to CTG), in the coding region of p53 mRNA, upstream to the second initiator codon (for DN-p53), had been recently shown to translationally deregulate the production on p53 isoforms. 16, 20 We report for the first time that a C-to-T SNP at 119th nucleotide in the p53 5 0 UTR actually deregulates the translational outcome of p53 mRNA. First, the IRES activity of the polymorphic 5 0 UTR is weaker. Second, this UTR binds PTB to a lesser extent and is not responsive to PTB silencing. Third, under conditions where IRES-mediated translation of fulllength p53 is preferred, the polymorphic 5 0 UTR does not fare as strongly as its WT counterpart in inducing translation.
As a result of these single-nucleotide changes, the association of p53 mRNA with the polysomes was found to change and there was a redistribution of the mRNA in the non-polysomal and polysomal fractions. In the case of SNP2-5 0 UTR, there is marked depletion in the polysomal pool and a corresponding increase in non-polysomal pool, indicating reduced translation efficiency from the IRES of this SNP2-5 0 UTR. Analysis of ribosome assembly on the SNP2-5 0 UTR indicates that the 80S interaction is altered. The 80S peak was found to be increased in this case. It is possible that the 60S ribosomal subunits and nonfunctional 80S ribosomes were trapped or functional 80S complexes were poorly cleared off the initiation codon of p53, similar to what was observed in presence of cycloheximide. Such increase was earlier reported in hepatits C virus IRES RNA mutants, where similar studies had shown that 80S peaks are higher compared with WT IRES. 24 Metabolic labeling followed by immunoprecipitation also suggested that the synthesis of p53 from SNP2-IRES is lower compared with WT-and SNP1-IRES. Also, C119T 5 0 UTR binds differentially to cellular proteins compared with the WT. Comparing the current results with a previous study 5 where biotinylated p53 5 0 UTR was used to pull down cellular RNA-binding proteins, it might be possible that p90 is heterogeneous ribonucleoprotein U, p70 is nucleolin, p54 is heat-shock cognate protein 54, p47 is casein kinase 1, gamma 2 and p40 is cold-shock domain-protein A.
It was earlier demonstrated that under conditions of doxorubicininduced DNA-damage stress, there is a differential increase in the IRES-mediated expression of p53, owing to cytoplasmic localization of PTB from the nucleus. 13 In general, DNA-damaging agents induce 5 0 UTR IRES-mediated translation of p53. Under such conditions, total p53 mRNA levels do not change, but p53 mRNA is associated more to the actively translating polyribosome fraction of total cellular RNA and less to the monosomes; also, treatment with translation blockers, such as cycloheximide, abrogates DNAdamage-induced p53 overexpression. 4 It had also been postulated that the same might happen at the mitotic phase when, naturally, IRES-mediated expression of p53 is high. 13, 14 In the current investigation, we show that this upregulation is seen with the WT 5 0 UTR but not with the polymorphic 5 0 UTR. Recently, it was also shown that p53 expression is mediated by its IRES upon overexpression of an activated form of Ras and forces primary cells to undergo oncogene-induced senescence. 9 In the face of a similar oncogenic insult, although in an already transformed cell line, the IRES activity of the polymorphic 5 0 UTR was found to be lesser than its WT counterpart. In both mitotic block and oncogenic insult, the fold induction in IRES activity for both WT and C-to-T polymorphic UTR seem to be similar, suggesting that ITAFs other than PTB have crucial roles in regulating IRESdependent translation of p53 mRNA. However, in either case, the IRES activity from the C-to-T 5 0 UTR lagged behind the WT 5 0 UTR. p53 produced from SNP2-IRES was slightly lesser in amount than that produced from WT IRES on doxorubicin treatment, and this decrease was enough to partially abrogate the cleavage of caspase-3, an executioner caspase for apoptosis.
p21 is a transcriptional target of p53. We used the readout of p21-promoter activity to assay the transactivation of p53 produced from WT, SNP1 and SNP2-5 0 UTRs. Because SNP2-IRES is weaker and produces less p53, as expected p21 promoter fired less compared with the other two cases. Nocodazole-mediated increase in IRES expression is also lesser from SNP2-IRES and there was no further increase in p21-promoter activity on nocodazole treatment when p53 was expressed from SNP2-IRES. Also, mRNA levels of known p53 transcriptional targets, such as p21 WAF1/CIP1 , BAX, PIDD, GADD45 and MDM2, were found to be lower for p53 produced from SNP2-5 0 UTR relative to that produced from WT 5 0 UTR. Although changes in mRNA degradation and/or stability cannot be ruled out completely for this effect, in our opinion the mRNA levels of these genes are lower, partly because p53 produced from SNP2-IRES is lesser in amount than that produced from WT IRES, resulting in lesser transactivation. In addition, the cell-cycle dynamics following release from a G1-S block was also different in cells expressing p53 from SNP2-5 0 UTR and WT 5 0 UTR, with more cells exhibiting earlier release (1.5 h) and faster progression to mitosis (8.5 h) for SNP2-5 0 UTR. Thus, these observations provide a physiological significance for the C-to-T change in the 5 0 UTR of p53 mRNA. Our study sheds some light on the possibilities of mutations or polymorphisms in the 5 0 UTR of p53, altering the translational Effect of SNP at the 5 0 UTR on p53 translation D Khan et al control of this nodal tumor-suppressor gene. Although little is known about the occurrence of this C-to-T polymorphism, the current data support the notion that extensive TP53 sequencing should include the whole TP53 gene and not only the exon encoding the DNA-binding domain; this is necessary to find polymorphisms and mutations that affect mRNA translation or mRNA splicing. Also, it would be interesting to investigate the degree to which this SNP and other such 5 0 UTR mutations are present in a cohort of patient samples.
MATERIALS AND METHODS

Foot-printing and toe-printing assays
For foot-printing assay, p53 RNA was incubated without or with increasing amounts of purified recombinant PTB protein. The RNA was digested with 0.5 U of RNase T1. The unmodified and digested RNAs were reverse transcribed and the resulting cDNAs were resolved in 8% acrylamide-7 M urea polyacrylamide gel electrophoresis (PAGE) in parallel with a sequencing reaction performed by using the same end-labeled primer. The results were analyzed using a PhosphorImager (Fujifilm, Tokyo, Japan).
For toe-printing assay, p53 RNA was incubated in absence or presence of purified recombinant PTB protein as described earlier. 25 The RNAs in the ribonucleoprotein complexes were reverse transcribed and the resulting cDNAs were resolved in 8% acrylamide-7 M urea PAGE in parallel with a sequencing reaction performed by using the same primer. The results were analyzed using a PhosphorImager.
Cell lines and transfections
H1299 and A549 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) (Sigma, St Louis, MO, USA) with 10% fetal bovine serum (FBS) (Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA). For luciferase assays, 70% confluent monolayers of H1299 or A549 were transfected with various bicistronic or monocistronic luciferase constructs using Lipofectamine-2000 (Invitrogen, Life Technologies) in OptiMEM (Invitrogen, Life Technologies). Four hours later, the medium was replaced with DMEM (with antibiotic) and 10% FBS. At the desired time point, the cells were harvested and dual-luciferase assays were performed by DLR assay reagent or Luciferase Assay System (Promega Corporation, Madison, WI, USA).
For stress induction, H1299 cells were transiently transfected with various constructs using Lipofectamine-2000. Twenty-four hours post transfection, the cells were treated with 2 mM doxorubicin (Sigma) for 8 h. Cells were harvested and dual-luciferase assays were performed or the cells were lysed for western blotting.
For studying the effects of oncogene overexpression, pBabe-H-RasV12 was transiently cotransfected with bicistronic luciferase constructs using Lipofectamine-2000 in OptiMEM. Four hours later, the medium was replaced with DMEM (with antibiotic) and 10% FBS. After 48 h, cells were lysed for dual-luciferase assays or for western blotting.
siRNA transfection PTB siRNA targeted a 19-nucleotide sequence located at nucleotides 1135-1153 of the PTB open reading frame. 26 As a control for silencing, a siCONTROL nontargeting siRNA no. 5 (Dharmacon, Thermo Scientific, Waltham, MA, USA) was used in the experiments in a similar manner as siRNA corresponding to PTB protein. Silencing by RNAi was performed as described elsewhere. 25 Briefly, cotransfection of 15 nM siRNA with various plasmid constructs was performed in H1299 cells growing in monolayer using Lipofectamine-2000 (Invitrogen, Life Technologies) transfection reagent in OptiMEM (Invitrogen). Forty-eight hours post transfection, the cells were harvested and the extracts were used for dual-luciferase assays or for western blot analysis.
Site-directed mutagenesis SNPs in p53 5
0 UTR were generated in pGFP-hp-p53-5 0 UTR-cDNA using two primers: a mutagenic reverse primer and an SP6-promoter-F primer pBabe-HRas V12 overexpression construct at various concentrations (100 and 500 ng). After 48 h, the cells were lysed and processed for immunoblotting.
Effect of SNP at the 5 0 UTR on p53 translation D Khan et al (the latter for high-fidelity copying of p53 cDNA) using QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Stratagene, Agilent Technologies, Santa Clara, CA, USA) as per the manufacturer's protocol. DNA was isolated from transformed Escherichia coli XL-10-Gold colonies and was verified by sequencing from Vimta Labs (Hyderabad, India). In the bicistronic constructs, these were generated by PCR amplification of template DNA using mutagenic primers and subsequent cloning in HindIII and EcoRI sites.
In vitro transcription
For comparative protein-binding analysis of p53 5 0 UTR mutants with respect to WT 5 0 UTR, the respective plasmid DNAs were PCR amplified using T7 promoter sequence-tagged p53 forward primer and WT or mutant-specific reverse primer. For in vitro ribosome loading experiments, the respective plasmid DNAs were amplified with the aforesaid forward primer and p53 150-165 reverse primer. All amplified DNAs were resolved and eluted from agarose gel using gel extraction kit (Qiagen, Venlo, The Netherlands) as per the manufacturer's instructions. The a-32 P-labeled RNA probes corresponding to WT and mutant plasmid DNAs were transcribed with T7 RNA polymerase and 10 mCi/ml of a-32 P-UTP (NEN, Perkin Elmer, Waltham, MA, USA) as per the manufacturer's instructions for UV crosslinking assays. Additionally, 40 U of RNase inhibitor (Promega) were included in each reaction in order to inhibit the activity of contaminating nucleases.
Protein purification
The expression of recombinant PTB was induced by 0.6 mM isopropyl b-D-1-thiogalactopyranoside in E. coli (BL21 DE3) cells transformed with the expression vector, pET28a-PTB. His-tagged protein was purified using Ni 2 þ -nitrilotriacetic acid agarose (Qiagen) under non-denaturing conditions and eluted with 250 mM imidazole.
Metabolic labeling and immunoprecipitation
A total of 6 Â 10 5 H1299 cells were seeded in 60-mm dishes 1 day prior to transfection. These were transfected with various constructs and grown in normal DMEM 10% FBS for 46 h. Then these were starved in MEM minus methionine medium for 1 h supplemented with 20 mM MG132. Then 35 S-methionine (10 mCi/ml, NEN) was added to a final concentration of 100 mCi/ml. After another 1 h, cells were harvested, frozen and then lysed in 250 ml ice-cold polysomal lysis buffer (10 mM HEPES pH 7.0, 100 mM KCl, 5 mM MgCl2, 0.5% NP-40, 1 mM DTT, 10% protease inhibitor cocktail and 100U/ml RNasin). A total of 40 ml protein-G-sepharose beads (Sigma) was incubated with 4 mg DO-1 antibody (sc-126, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 5 h at 4 1C. In all, 10 ml of this slurry was incubated with 400 mg of precleared (by protein-G-sepharose) cell lysate overnight at 4 1C for immunoprecipitation of p53. Beads were spun down at 8000 r.p.m. for 2 min, washed four times in ice-cold polysomal lysis buffer and spun down similarly. Protein-bound beads were boiled in sodium dodecyl sulfate (SDS)-loading buffer and resolved in a 12% SDS-PAGE. The gel was fixed in 1 M sodium salicylate, dried and results were viewed in a PhosphorImager.
Preparation of S10 extracts S10 extracts were prepared as described elsewhere. 27 Briefly, A549 cells were grown in DMEM (Sigma), supplemented with 10% FBS (Gibco, Invitrogen). A monolayer of A549 cells was harvested, pelleted down and washed three times with cold isotonic buffer (35 mM HEPES pH 7.4, 146 mM NaCl and 11 mM glucose), resuspended in 1.5 Â packed cell volume of hypotonic buffer (10 mM HEPES pH 7.4, 15 mM KCl, 1.5 mM Mg-acetate and 6 mM b-ME) and then incubated on ice for 10 min for swelling. Cells were then transferred to a Down's Homogenizer (Sigma) and disrupted by 50 strokes on ice. The lysate was incubated in 1 Â incubation buffer (10 Â : 200 mM HEPES, 1.2 M KCl, 50 mM Mg-acetate and 60 mM b-mercaptoethanol) for 10 min. Cytoplasmic extract (S10 supernatant) was isolated by centrifuging the lysate at 10 000 g for 30 min at 4 1C. The supernatant was treated with 75 U of micrococcal nuclease (Fermentas, Thermo Scientific, Waltham, MA, USA), subsequently inactivated by addition of 2 mM EGTA and dialyzed for 2-4 h against 100 volumes of dialysis buffer (10 mM HEPES, 90 mM KCl, 1.5 mM Mg-acetate, 7 mM b-ME and 20% glycerol). The protein contents of the S10 extracts were estimated by Bradford's method using a bovine serum albumin standard curve. UV-induced cross-linking of proteins and RNA UV-induced cross-linking was carried out as described elsewhere. 13 Briefly, a-32 P RNA probes were allowed to form complexes with S10 extracts or with recombinant PTB at 30 1C for 25 min in 1 Â RNA-binding buffer and then irradiated with a hand-held UV lamp for 20 min. The mixture was treated with 30 mg of RNase A (Sigma) at 37 1C for 30 min The proteinnucleotidyl complexes were electrophoresed on 10% SDS-PAGE and analyzed by phosphorimaging.
Electrophoretic mobility shift assay
Conditions for electrophoretic mobility shift assay have been previously described. 28 (c) H1299 cells were transiently cotransfected with pGFP-hp-p53 cDNA (WT or SNP2). After 48 h, total RNA was isolated, cDNA was synthesized and real-time PCR was done for six genes that are transactivated by p53. Results are represented as percentage mRNA levels seen in SNP2 relative to 100 percent in WT. p21, WAF1/CIP1; BAX, Bcl2-associated X protein; PIDD, p53-induced death domain protein; GADD45, growth arrest and DNA-damage-inducible protein; SFN, stratifin (14-3-3-sigma protein); MDM2, murine double minute 2.
Sucrose-gradient centrifugation analysis of ribosomal assembly on p53 IRES
In vitro translation of the first 165 nucleotides of p53 message (p53 WT-or SNP2-5 0 UTR and 30 downstream nucleotides) was set up in rabbit reticulocyte lysates (RRL, Promega Corporation). Briefly, 25 ml reaction mixtures containing 17.5 ml of RRL, 0.25 ml each of minus methionine and minus leucine mixtures, 10 U of RiboLock (Fermentas) and required amount of 32 P-radiolabelled RNA corresponding to specific activity of 10 5 c.p.m. were incubated at 30 1C for 15 min, with or without 500 mM cycloheximide. The reactions were stalled by chilling on ice, diluted to 175 ml with ice-cold gradient buffer (20 mM Tris pH 7.5, 100 mM KCl, 3 mM MgCl 2 and 1 mM DTT) and overlaid on 5-30% (w/v) linear sucrose gradient. The ribosomal complexes were sedimented by ultracentrifugation for 3 h at 4 1C and 30 000 r.p.m. in Sorvall Th-641 (Thermo Scientific) swing bucket rotor. A total of sixteen 550 ml fractions were manually collected from the top of the tube and counted in a LKB Rackbeta (Perkin Elmer) liquid scintillation counter.
RNA isolation, semiquantitative reverse-transcriptase PCR and real-time PCR Total RNA was isolated from H1299 cells using TRI reagent (Sigma) as per the manufacturer's protocol, treated with 10 U of DNase per sample and extracted by phenol-chloroform method.
First-strand cDNA was synthesized from 1 mg of RNA using oligo-(dT) 18 primer (Fermentas) or 18S rRNA reverse primer using Revert-Aid RT enzyme (Fermentas). Equal volumes of cDNA were used to amplify p53 or 18S rRNA using the following primers and the resulting amplicons were resolved on 2% agarose gel:
p53 
Statistical analysis
The data were expressed as mean±s.d. Statistical significance was determined using two-sided Student's t-test. The criterion for statistical significance was Po0.05.
